Renaissance Capital logo

Amanat Acquisition Priced, Nasdaq: AMAN

Blank check company targeting the life sciences industry led by biotech executive Sandeep Kulkarni.

Industry: SPAC

Latest Trade: $10.13 0.00 (0.0%)

First Day Return: +0.1%

Return from IPO: +1.3%

Industry: SPAC

We are a blank check company. While we may pursue a business combination target in any business or industry, we intend to focus on healthcare or healthcare-related industries, which can benefit from the expertise and capabilities of our management team in order to create long-term shareholder value. Our sponsor, Amanat Sponsor Holdings LLC, is a Delaware limited liability company which was formed to invest in us. Although our sponsor is permitted to undertake any activities permitted under the Delaware Limited Liability Company Act and other applicable law, our sponsor’s business is focused on investing in us and directly or indirectly providing administrative services to members of our management team. As of the date of this prospectus, our Chairman of the Board, Dr. Sandeep Kulkarni is the sole member of our sponsor.
more less
IPO Data
IPO File Date 04/17/2026
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 7.5
Deal Size ($mm) $75
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 05/18/2026
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 7.5
Deal Size ($mm) $75
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Leerink Partners
Company Data
Headquarters Westfield, NJ, United States
Founded 2026
Employees at IPO 2
Website amanatacquisition.com

Amanat Acquisition (AMAN) Performance